Evaluation of serum levels of solubilized adhesion molecules in patients with aortocoronary saphenous vein grafts

Coronary Artery Disease

Volumn 16, Issue 7, 2005, Pages 431-436

  Aras, Dursun ^a,b   Erbay, Ali R ^a   Maden, Orhan ^a   Topaloglu, Serkan ^a   Ozbakir, Cemal ^a   Ozdemir, Ozcan ^a   Cagli, Kerim ^a   Demir, Ahmet D ^a   Soylu, Mustafa ^a   Kisacik, Halil L ^a   Korkmaz, Sule ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Adhesion molecules; Coronary artery surgery; Saphenous vein grafts

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORRELATION ANALYSIS; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAPHENOUS VEIN GRAFT; SENSITIVITY AND SPECIFICITY; SOLUBILIZATION; STENOSIS; VEIN GRAFT DISEASE;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET ACTIVATION; PREDICTIVE VALUE OF TESTS; SAPHENOUS VEIN;

EID: 27344455034     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200510000-00003     Document Type: Article

References (29)

1. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989; 79(Pt 2):124-129.
2. Bourassa MG, Enjalbert M, Campeau L, Lesperance J. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol 1984; 53:102C-107C.
3. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991; 34:45-68.
4. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990; 248:1009-1012.
5. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65:297-302.
6. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994; 24:1591-1601.
7. Price DT, Loscaizo J. Cellular adhesion molecules and atherogenesis. Am J Med 1999; 107:85-97
8. Chester AH, Borland JA, Taylor PM, Rose ML, Yacoub MH. Vascular adhesion molecules and immunogenicity in blood vessels used as coronary artery bypass grafts. Eur J Cardiothorac Surg 1996; 10:676-683.
9. Chester AH, Morrison KJM, Yacoub MH. Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts. Ann Thorac Surg 1998; 65:1685-1689.
10. Hoff HF, Beck GJ, Skibinski CI, Jurgens G, O'Neil J, Kramer J, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 77:1238-1244.
11. Walpola PL, Gotlieb AI, Cybulsky MI, Langille BL. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol 1995; 15:2-10.
12. Deng MC, Wiedner M, Erren M, Mollhoff T, Assmann G, Scheid HH, et al. Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 1995; 9:22-29.
13. Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr, Gimbrone MA Jr. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 1994; 94:885-891.
14. Isner JM, Kishel J, Kent KM, Ronan JA Jr, Ross AM, Roberts WC. Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic-histologic correlative analysis in 28 patients. Circulation 1981; 63:1056-1064.
15. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93:11877-11882.
16. Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77:1081-1085.
17. Blaha M, Krejsek J, Blaha V, Andrys J, Vokurkova D, Maly J, et al. Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity. Physiol Res 2004; 53:273-278.
18. Keating FK, Whitaker DA, Kabbani SS, Ricci MA, Sobel BA, Schneider DJ. Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis. Am J Cardiol 2004; 94:725-728.
19. Catinella FP, Cunningham JN Jr, Srungaram RK, Baumann FG, Nathan IM, Glassman EA, et al. The factors influencing early patency of coronary artery bypass vein grafts. J Thorac Cardiovasc Surg 1982; 83:686.
20. Walts AE, Fishbein MC, Sustaita H, Matloff JM. Ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: a mechanism of acute, thrombotic, late graft occlusion. Circulation 1982; 65:197-201.
21. Neitzel GF, Barboriak JJ, Pintar K, Qureshi I. Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis 1986; 6:594-600.
22. Dewanjee MK, Tago M, Josa M, Fuster V, Kaye MP. Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin. Circulation 1984; 69:350-356.
23. Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive chenges in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997; 336:153-162.
24. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, II: maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994; 308:159-168.
25. Bhatt DL, Topol EJ. Antiplatelet and anticoagulant therapy in the secondary prevention of ichemic heart disease. Med Clin North Am 2000; 84:163-179.
26. Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, et al. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res 1992; 70:39-48.
27. Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 2001; 103:363-368.
28. Campeau L, Enjalbert M, Lesperance J, Bourassa MG, Kwiterovich P Jr, Wacholder S, et al. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984; 311:1329-1332.
29. Lie JT, Lawrie GM, Morris GC. Aortocoronary bypass saphenous vein graft atherosclerosis: anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol 1977; 40:906-914.